Article Details

GLEAMER Receives FDA Clearance for Its Artificial Intelligence Software to Help Detect and ...

Retrieved on: 2022-03-02 21:34:50

Tags for this article:

Click the tags to see associated articles and topics

GLEAMER Receives FDA Clearance for Its Artificial Intelligence Software to Help Detect and .... View article details on hiswai:

Excerpt

PARIS, March 2, 2022 /PRNewswire/ -- GLEAMER, a French medtech company pioneering the use of artificial intelligence technology in the practice of ...

Article found on: www.wfmz.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up